Hypomanic Episode in CADASIL Syndrome
___
1. Valenti R, Pescini F, Antonini S, Castellini G, Poggesi A, Bianchi S, Inzitari D, Pallanti S, Pantoni L. Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semistructered interview. Acta Neurol Scand 2011; 124:390-395. [CrossRef]2. Valenti R, Poggesi A, Pescini F, Inzitari D, Pantoni L. Psychiatric disturbances in CADASIL: Aabrief review. Acta Neurol Scand 2008; 118:291-295. [CrossRef]
3. Lagas PA, Juvonen V. Schizophrenia in a patient with cerebral autosomally dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL disease). Nord J Psychiatry 2001; 55:41-42. [CrossRef]
4. Chabriat H, Bousser MG. Neuropsychiatric manifestations in CADASIL. Dialogues Clin Neurosci 2007; 9:199-208.
5. Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 1999; 30:1230-1233. [CrossRef]
6. Over MF. Clinical And Laboratuary Characteristics of White Matter Lesion in Migraine Patients. Speciality thesis, Cukurova University Faculty of Medicine, Adana, 2008. (Turkish)
7. Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ, Harris GJ, Geer M, Peyser CE, Pearlson GD. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry 1994; 151:687-693. [CrossRef]
8. Kesebir S, Koca EK, Kilicaslan EE. CADASIL Syndrome presenting with bipolar disorder. Journal of Mood Disorders 2010; 2:115- 118. (Turkish) [CrossRef]
9. Yuan P, Salvadore G, Li X, Zhang L, Du J, Chen G, Manji HK. Valproate activates the Notch3/c-Flip signaling cascade: a strategy to attenuate white matter hyperintensities in bipolar disorder in late life? Bipolar Disord 2009; 11:256-269. [CrossRef]
10. Mahon K, Burdick KE, Szeszko PR. A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci Biobehav Rev 2010; 34:533-554. [CrossRef]
11. Ruchoux MM, Domenga V, Brulin P, Maciazek J, Limol S, Tournier-Lasserve E, Joutel A. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol 2003; 162:329- 342. [CrossRef]
12. Dubroca C, Lacombe P, Domenga V, Maciazek J, Levy B, Tournier-Lasserve E, Joutel A, Henrion D. Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke 2005; 36:113-117. [CrossRef]
- ISSN: 1018-8681
- Yayın Aralığı: Yılda 4 Sayı
- Başlangıç: 1984
- Yayıncı: Kare Yayıncılık
Filiz İZCİ, Ebru FINDIKLI, Serkan ZİNCİR, Akif CAMKURT, Ozlem KİZİLKURT, Ferzan GİYNAS, SEVDA KORKMAZ, Emin Barış AKIN
Selma TURAL HESAPÇIOĞLU, MEHMET FATİH CEYLAN, BETÜL ÇELİK ERDOĞAN, Gozde KANDEMİR, ESRA ÇÖP
Cüneyt EVREN, Gökhan UMUT, Bilge EVREN
Sermin Yalin SAPMAZ, Handan Özek ERKURAN, DİLEK ERGİN, NESRİN ŞEN CELASİN, DUYGU KARAARSLAN, Masum OZTURK, Ertuğrul KÖROĞLU, ÖMER AYDEMİR
Medroxyprogesterone Acetate-Induced Mania in a Patient with Bipolar Affective Disorder
Memduha AYDIN, Bilge Cetin ILHAN, Abdulbaki AKYİLDİZ, İbrahim EREN
Evidence Based Criteria for the Antidepressant Choice
Serum Apelin And Nesfatin-1 Levels in Depression Patients and Their Relationship with Treatment
Şahap DEDE, Musa ŞAHPOLAT, MEHMET HANİFİ KOKAÇYA, Mustafa ARI, Cem SESLİOKUYUCU, Zafer YÖNDEN
Co-Occurrence of Autism Spectrum Disorder and Very Early Onset Schizophrenia: a Case Report
Duygu KABA, Pinar URAN, Ayla SOYKAN AYSEV
Gamma-hydroxybutyrate (GHB): an Emerging Substance of Abuse
ÜRÜN ÖZER ÇERİ, Mert BATMAZ, Ibrahim AKBAS